thromboembolism

(redirected from thromboembolic)
Also found in: Dictionary, Thesaurus, Medical.
Related to thromboembolic: thrombotic, Thromboembolic disease

thromboembolism

[¦thräm·bō′em·bə‚liz·əm]
(medicine)
An embolism resulting from a dislodged thrombus or part of a thrombus.
References in periodicals archive ?
0 led to reduced rates of thromboembolic events and intracranial hemorrhages, regardless of the patients' ages.
5 additional incidents of thromboembolic disease per 10,000 woman years, approximately 4 additional deaths per 1,000,000 woman years.
They went on to note that "general risk factors for thromboembolic events include previous history of thromboses, surgery, and prolonged periods of immobilization or limited activity.
Unfortunately, the dose of vitamin D used in the placebo group was less than that shown in other trials to prevent fractures, so it is likely that the true benefit of raloxifene over calcium and vitamin D alone is less than is reported in this trial,l Although raloxifene lowers the short-term risk of breast cancer in postmenopausal women, the risk of thromboembolic events is as high as that with estrogen.
Probably more important than any type of mechanical compression or chemical prophylaxis [in preventing bleeding and venous thromboembolic events] is our emphasis on getting patients out of bed on postoperative day zero," Dr.
South Korean biopharmaceutical company GC Pharma (Green Cross Corporation) (KRX:006280) reported on Tuesday the launch of an agreement to grant its exclusive rights to develop and commercialise GCC-4401C for the prevention and treatment of thromboembolic disease.
Chronic thromboembolic pulmonary hypertension (CTEPH) is a disease, in which an organized thrombus in the proximal pulmonary artery accompanied by distal vascular remodeling causes obstruction of the pulmonary artery and arterioles.
SRNS patients are at a higher risk of developing thromboembolic complications compared with steroid-sensitive NS patients.
Traditionally, bridging anticoagulation therapies have been used with heparin based on the argument that suspending the anticoagulation for long periods of time increases the risk of thromboembolic events.
USPRwire, Tue Sep 23 2014] GlobalData's clinical trial report, "Chronic Thromboembolic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Chronic Thromboembolic Pulmonary Hypertension clinical trial scenario.